Focusing on a distant goal right away can be discouraging. Verge Genomics founder and CEO Alice Zhang examines her early “number of drugs discovered” benchmark, and describes how more intermediate goals-for example, around technical accomplishments rather than completed products-sometimes make better benchmarks for young companies with long product development cycles.
Related
Ashley Flucas,
Flucas Ventures
The New Angel Investing [Entire Talk]
New users are flocking to angel investing platforms. What does this mean for investors and startups?
Ashley Flucas,
Flucas Ventures
The New Angel Investing [Entire Talk]
New users are flocking to angel investing platforms. What does this mean for investors and startups?
Jon Zieger,
Responsible Innovation Labs
What is Responsible Innovation? [Entire Talk]
Ambitious technology companies will shape the 21st century. Could new frameworks help them shape it in a positive direction?
Jon Zieger,
Responsible Innovation Labs
What is Responsible Innovation? [Entire Talk]
Ambitious technology companies will shape the 21st century. Could new frameworks help them shape it in a positive direction?
Luke Sykora,
Stanford University
How to Rethink Competition
Pay attention to competitors, sure. But to catalyze innovation, pay attention to more than the usual suspects.